Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desloratadine suppression of allergen-induced wheal and flare
NCT00359138Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- Feb 2006
- Primary completion
- May 2006
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of desloratadine in Hypersensitivity (3 arms), sponsored by Organon & Co. Primary endpoint: Duration of Suppressive Effect of Desloratadine After Discontinuation of a 1-week Treatment. Started Feb 2006; status: completed.
02
Drugs
desloratadine
03
Conditions
Hypersensitivity
Beyond the preview
Go deeper on NCT00359138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00359138.